Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 May 14;65(Pt 6):o1286.
doi: 10.1107/S1600536809017085.

Darifenacin hydro-bromide

Darifenacin hydro-bromide

S Selvanayagam et al. Acta Crystallogr Sect E Struct Rep Online. .

Abstract

In the title compound {systematic name: (S)-3-[(aminocar-bonyl)diphenylmethyl]-1-[2-(2,3-di-hy-dro-benzofuran-5-yl)ethyl]pyrrolidinium bromide}, C(28)H(31)N(2)O(2) (+)·Br(-), the pyrrolidine rings adopts an envelope conformation. The two phenyl rings make a dihedral angle of 72.5 (1)°. The four coplanar atoms of the pyrrolidine ring makes dihedral angles of 33.1 (2) and 82.8 (2)° with the two phenyl rings. The mol-ecular conformation is influenced by a C-H⋯O inter-action. In the crystal packing, there are two N-H⋯Br hydrogen bonds running in opposite directions. They appear to form C(10) and C(9) chain motifs in the unit cell. In addition, the mol-ecular packing is further stabilized by C-H⋯Br and C-H⋯O hydrogen bonds. The C atom bonded to the benzofuran ring system is disordered in a 0.66:0.34 ratio.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
The structure and atom-numbering scheme for (I); displacement ellipsoids are drawn at the 30% probability level.
Fig. 2.
Fig. 2.
Molecular packing of (I) viewed down the b axis; H-bonds are shown as dashed lines. For the sake of clarity, H atoms, not involved in hydrogen bonds, have been omitted.

Similar articles

Cited by

References

    1. Allen, F. H., Kennard, O., Watson, D. G., Brammer, L., Orpen, A. G. & Taylor, R. (1987). J. Chem. Soc. Perkin Trans. 2, pp. S1–S19.
    1. Bruker (2001). SMART andSAINT Bruker AXS Inc., Madison, Wisconsin, USA.
    1. Chapple, C. R. (2004). Expert Opin. Investig. Drugs, 13, 1493–1500. - PubMed
    1. Cremer, D. & Pople, J. A. (1975). J. Am. Chem. Soc 97, 1354–1358.
    1. Croom, K. F. & Keating, G. M. (2004). Drugs Aging, 21, 885-892. - PubMed